ImmuCell Reports More Advance Q4 Sales (NASDAQ: ICCC)


  • ImmuCell Corporation (NASDAQ:ICCC) announced preliminary sales of $7.8 million in the fourth quarter, up 52% ​​from the fourth quarter of 2023.
  • Co sees fiscal 2024 sales of $26.5 million, also up 52% ​​from 2023.
  • The company believes the current backlog reflects strong demand as distributors work to replenish their buffer stocks and as end users place orders ahead of the peak calving season in the first quarter.
  • Source: Press release



Source link

  • Related Posts

    The 10-year Treasury yield is unnerving the market: Morning Brief

    That’s The Takeaway from the Morning Brief today, that you can sign up to receive in your inbox every morning along with: Last year, as Treasury yields rose, most stocks…

    The Earth recorded the hottest year since 2024 and the jump was so big that it crossed the 1.5 degree Celsius threshold.

    “It’s a warning light shining on Earth’s dashboard that needs immediate attention,” said University of Georgia meteorology professor Marshall Shepherd. Read More Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *